LATAM News Online
SEE OTHER BRANDS

The latest news from Latin America

LATAM News Online: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on LATAM News Online.

Press releases published on July 30, 2025

Camarones al mojo de ajo en Amaral, restaurante en Polanco para comer cocina mediterránea

Camarones al mojo de ajo en Amaral, restaurante en Polanco para comer cocina mediterránea

Disfruta camarones al mojo de ajo en Amaral, restaurante en Polanco para comer cocina mediterránea en un ambiente elegante MEXICO CITY , MEXICO, July 30, 2025 /⁨EINPresswire.com⁩/ -- Los camarones al mojo de ajo son un platillo muy conocido y siempre …

Arvinas to Report Second Quarter 2025 Financial Results on August 6, 2025

Arvinas to Report Second Quarter 2025 Financial Results on August 6, 2025

NEW HAVEN, Conn., July 30, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that management will review financial results from …

Revolution Medicines to Report Financial Results for Second Quarter 2025 After Market Close on August 6, 2025

Revolution Medicines to Report Financial Results for Second Quarter 2025 After Market Close on August 6, 2025

REDWOOD CITY, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced that it will report financial …

Codexis to Report Second Quarter 2025 Financial Results on August 13

Codexis to Report Second Quarter 2025 Financial Results on August 13

REDWOOD CITY, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for the efficient and scalable manufacturing of complex therapeutics, today announced that it will report its financial results …

Aligos Therapeutics to Announce 2nd Quarter 2025 Financial Results on August 6, 2025

Aligos Therapeutics to Announce 2nd Quarter 2025 Financial Results on August 6, 2025

SOUTH SAN FRANCISCO, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biotechnology company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today …

Appointment of Director to the Board

Appointment of Director to the Board

Golar LNG Limited (“Golar”) (Nasdaq: “GLNG”) is pleased to announce that effective August 1, 2025, Mr. Stephen J. Schaefer will join its Board of Directors. Mr. Schaefer brings extensive experience in the natural gas and electricity markets, having been …

LYNO Launches Stage 1 of Token Presale, Introducing AI-Powered Arbitrage Protocol Across 15+ Chains

LYNO Launches Stage 1 of Token Presale, Introducing AI-Powered Arbitrage Protocol Across 15+ Chains

ROAD TOWN, British Virgin Islands, July 30, 2025 (GLOBE NEWSWIRE) -- LYNO, a decentralized cross-chain arbitrage protocol powered by artificial intelligence, has officially launched Stage 1 of its token presale. Designed to democratize arbitrage trading …

LYNO Debuts Presale Offering for AI-Powered Arbitrage Token

LYNO Debuts Presale Offering for AI-Powered Arbitrage Token

ROAD TOWN, British Virgin Islands, July 30, 2025 (GLOBE NEWSWIRE) -- The team behind $LYNO has officially launched the first phase of its presale for a decentralized, AI-powered cross-chain arbitrage protocol designed to operate across more than 15 EVM- …

Elcora Announces Late Filing of Annual Financial Statements and Management Cease Trade Order

Elcora Announces Late Filing of Annual Financial Statements and Management Cease Trade Order

HALIFAX, Nova Scotia, July 30, 2025 (GLOBE NEWSWIRE) -- ELCORA ADVANCED MATERIALS CORP. (TSX.V:ERA | Frankfurt:ELM0 | OTCQB – ECORF), (the "Company" or "Elcora"), announces today that, as a result of delays to its audit, the Company’s annual financial …

Bitget Wallet Launches $777K Altventure Campaign as Altseason Momentum Builds

Bitget Wallet Launches $777K Altventure Campaign as Altseason Momentum Builds

SAN SALVADOR, El Salvador, July 30, 2025 (GLOBE NEWSWIRE) -- Bitget Wallet, the leading non-custodial crypto wallet, has launched Altventure, a month-long initiative designed to help users navigate the evolving altcoin market. With a $777,000 prize pool …

NeuroStar Announces New Publication in JAACAP Open Highlighting Treatment Efficacy in Depressed Adolescents

NeuroStar Announces New Publication in JAACAP Open Highlighting Treatment Efficacy in Depressed Adolescents

MALVERN, Pa., July 30, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, …

Protagenic Therapeutics Announces Grant of new patent in Japan for its Modified Stilbenoid Program Drug Candidates

Protagenic Therapeutics Announces Grant of new patent in Japan for its Modified Stilbenoid Program Drug Candidates

NEW YORK and SANTA BARBARA, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Protagenic Therapeutics, Inc. (Nasdaq: PTIX) (the “Company”) today announces that on July 18, 2025, the Japanese Patent Office granted Patent JP 7714571B, a patent which runs until March …

Tenaya Receives Positive Safety Reviews from Independent DSMBs to Advance Both TN-201 and TN-401 Gene Therapy Clinical Trials as Designed

Tenaya Receives Positive Safety Reviews from Independent DSMBs to Advance Both TN-201 and TN-401 Gene Therapy Clinical Trials as Designed

Enrollment in Both Dose Cohorts of the MyPEAK™-1 Phase 1b/2 Clinical Trial of TN-201 for Hypertrophic Cardiomyopathy (HCM) Complete; Follow-up Data from Cohort 1 and Initial Data from Cohort 2 Expected in Fourth Quarter of 2025 First Patient Dosed in 6E13 …

Clearmind Medicine Files International Patent Application for Novel Combination Therapy Targeting Weight Loss and Fatty Liver Disease

Clearmind Medicine Files International Patent Application for Novel Combination Therapy Targeting Weight Loss and Fatty Liver Disease

Vancouver, Canada, July 30, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to …

Maxus Mining Expands Land Holdings at the Quarry Antimony Project in British Columbia, Canada

Maxus Mining Expands Land Holdings at the Quarry Antimony Project in British Columbia, Canada

VANCOUVER, British Columbia, July 30, 2025 (GLOBE NEWSWIRE) -- Maxus Mining Inc. (“Maxus” or the “Company”) (CSE: MAXM | FRA: R7V), is pleased to announce that the Company has expanded its land holdings through strategic staking of an additional 1,803 …

Skyharbour Expands Uranium Exploration Portfolio to Over 616,000 Hectares Across Thirty-Seven Projects in the Athabasca Basin, Northern Saskatchewan

Skyharbour Expands Uranium Exploration Portfolio to Over 616,000 Hectares Across Thirty-Seven Projects in the Athabasca Basin, Northern Saskatchewan

Vancouver, BC, July 30, 2025 (GLOBE NEWSWIRE) -- Skyharbour Resources Ltd. (TSX-V: SYH) (OTCQX: SYHBF) (Frankfurt: SC1P) (“Skyharbour” or the “Company”), is pleased to announce that it has acquired, through inexpensive online staking, 21 new prospective …

ORYZON Reports Financial Results and Corporate Update for Half-Year Ending June 30, 2025

ORYZON Reports Financial Results and Corporate Update for Half-Year Ending June 30, 2025

Between December 2024 and July 2025, Oryzon secured financing totaling €52 M, approx. $61 M (€30.0 M from a capital increase, €7.0 M from commercial bank loans, €13.2 M from the EU-IPCEI grant, and €1.8 M from R…

Aventis Energy Announces Management Changes

Aventis Energy Announces Management Changes

VANCOUVER, British Columbia, July 30, 2025 (GLOBE NEWSWIRE) -- Aventis Energy (“Aventis” or the “Company”) (CSE:AVE | FRA:C0O0 | OTC: VBAMF) is pleased to announce the appointment of Michael Mulberry, current Director of Aventis, as Chief Executive Officer …

Nautilus Biotechnology Announces Agreement with the Allen Institute, Further Validating its Approach to Single-Molecule Proteomics

Nautilus Biotechnology Announces Agreement with the Allen Institute, Further Validating its Approach to Single-Molecule Proteomics

• Allen Institute to employ Iterative Mapping, Nautilus’ single-molecule proteomics method, to investigate connection between tau protein and Alzheimer’s disease • Agreement links the organizations’ next-generation proteomics technology and neuroscience …

American Tungsten Announces Strategic Advancements in IMA Mine Rehabilitation and Exploration Program

American Tungsten Announces Strategic Advancements in IMA Mine Rehabilitation and Exploration Program

Vancouver, BC, July 30, 2025 (GLOBE NEWSWIRE) -- American Tungsten Corp. (CSE:TUNG) (OTCQB:DEMRF) (FSE:RK9) (“American Tungsten” or the “Company”) is pleased to provide a corporate update on its ongoing efforts to rehabilitate the historic IMA Mine in …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions